GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review.

RPEP-077642024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review.
Published In:
Journal of clinical & translational endocrinology, 35, 100333 (2024)
Database ID:
RPEP-07764

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07764·https://rethinkpeptides.com/research/RPEP-07764

APA

Aoun, Laurence; Almardini, Shaza; Saliba, Fares; Haddadin, Fadi; Mourad, Omar; Jdaidani, Jennifer; Morcos, Zeina; Al Saidi, Ibrahim; Bou Sanayeh, Elie; Saliba, Saliba; Almardini, Michel; Zaidan, Julie. (2024). GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review.. Journal of clinical & translational endocrinology, 35, 100333. https://doi.org/10.1016/j.jcte.2024.100333

MLA

Aoun, Laurence, et al. "GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review.." Journal of clinical & translational endocrinology, 2024. https://doi.org/10.1016/j.jcte.2024.100333

RethinkPeptides

RethinkPeptides Research Database. "GLP-1 receptor agonists: A novel pharmacotherapy for binge e..." RPEP-07764. Retrieved from https://rethinkpeptides.com/research/aoun-2024-glp1-receptor-agonists-a

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.